FindTrial
Sign In

A Study to Evaluate the Effectiveness of Sivanar Vembu Kuzhi Thailam in the Management of Urticaria(Kaanakadi).

An Open Label Single Arm Clinical Trial to evaluate the Effectiveness of Sivanar Vembu Kuzhi Thailam (Both Internal and External Medicine ) in the management of Kaanakadi (Urticaria)among patients reporting at Ayothidoss Pandithar Hospital,National Institute of Siddha. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106767
Enrollment
30
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

Intervention1: Sivanar Vembu Kuzhi Thailam: Internal Medicine-Dose-8 Drops-Twice a day, Adjuvant-Sarkarai, Duration-48 days Intervention2: Sivanar Vembu Kuzhi Thailam: External Application for 48 days

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants with clinical symptoms of itching, burning sensation, erythema, pale pink edematous wheal formation, wheals surrounded by flare.

Exclusion criteria

Exclusion criteria: Participants aged less than 13 years and those aged above 60 years, Evidence of any skin condition other than urticaria, angioedema, narcotic addicts, Pregnancy and lactation, Diabetes mellitus, hypertension.

Design outcomes

Primary

MeasureTime frame
Reduction in clinical symptoms based on Urticaria Activity Score over 7 days, Chronic urticaria quality of life Questionnaire and clinical laboratory blood parameters such as IgE, AEC, ESR and CRP.Timepoint: 18 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactProf Dr R Madhvan

National Institute of Siddha

drmadhavanji@gmail.com9965561656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026